News Quantified

FLGT – fulgent genetics, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Fulgent Genetics to buy Bako Diagnostics assets and StrataDx [Yahoo! Finance]

Fulgent Genetics Agrees to Acquire Bako Diagnostics and StrataDx [Yahoo! Finance]

Fulgent Genetics Agrees to Acquire Bako Diagnostics and StrataDx

Fulgent Genetics: From Genetic Code To Cancer Cure - Why I Assign A Hold Rating [Seeking Alpha]

Fulgent Genetics (NASDAQ:FLGT) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..

12.4%

BEAT

7.9%

BEAT

14.2%

BEAT

-1.5%

BEAT

Raymond James Financial, Inc.

Form 8-K Fulgent Genetics, Inc. For: Dec 20

Form 4 Fulgent Genetics, Inc. For: Dec 02 Filed by: Xie Jian

Form 4 Fulgent Genetics, Inc. For: Dec 01 Filed by: Kim Paul

Form 4 Fulgent Genetics, Inc. For: Dec 02 Filed by: Gao Hanlin

Form 4 Fulgent Genetics, Inc. For: Nov 28 Filed by: Xie Jian

Top News Gainers

11/4 Q3/2019 9/30/2019 EPS 0.140 ZacksConsensus 0.010 ActVsEst 0.130 - Beat 38.4%

8/5 Fulgent Genetics Reports Second Quarter 2019 Financial Results 27.5%

11/8 Form 10-Q Fulgent Genetics, Inc. For: Sep 30 26.6%

3/17 Fulgent Genetics Announces Launch of Next Generation Sequencing (NGS) Test to Detect Coronavirus Disease (COVID-19) 16.1%

2/14 Fulgent Genetics Inc (NASDAQ: FLGT) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 8.6%

6/3 Form 4 Fulgent Genetics, Inc. For: May 30 Filed by: BOLGER JOHN C 8.3%

4/29 Fulgent Genetics Inc (NASDAQ: FLGT) was upgraded by analysts at BidaskClub from a "buy" rating to a "strong-buy" rating. 7.1%

3/13 Form 10-K Fulgent Genetics, Inc. For: Dec 31 6.7%

12/22 Is KVH Industries, Inc. (KVHI) A Good Stock To Buy? [Yahoo! Finance News] 6.4%

8/5 Form 8-K Fulgent Genetics, Inc. For: Aug 01 3.9%

Top News Decliners

3/10 Fulgent Genetics Reports Fourth Quarter and Full Year 2019 Financial Results -34.1%

11/13 Fulgent Genetics Announces Proposed Public Offering of Common Stock -18.5%

3/12 Fulgent Genetics Inc (NASDAQ: FLGT) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. -17.7%

2/21 Fulgent Genetics Inc (NASDAQ: FLGT) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -11.3%

5/7 Q1/2019 3/31/2019 EPS -0.060 ZacksConsensus -0.060 ActVsEst 0.000 - In-Line -10.1%

11/5 Form 4 Fulgent Genetics, Inc. For: Nov 01 Filed by: KIM PAUL -8.3%

10/8 Fulgent Genetics Inc (NASDAQ: FLGT) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. -7.6%

8/7 Fulgent Genetics Inc (NASDAQ: FLGT) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -7.3%

2/20 Fulgent Genetics to Announce Fourth Quarter and Full Year 2019 Financial Results on Tuesday March 10, 2020 -7.1%

8/12 Form S-3 Fulgent Genetics, Inc. -6.4%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day